<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Chelation therapy | HOPO Therapeutics</title>
    <link>/tags/chelation-therapy/</link>
      <atom:link href="/tags/chelation-therapy/index.xml" rel="self" type="application/rss+xml" />
    <description>Chelation therapy</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Â© 2020 HOPO Therapeutics, Inc.</copyright><lastBuildDate>Sat, 01 Apr 2017 00:00:00 +0000</lastBuildDate>
    <image>
      <url>img/map[gravatar:%!s(bool=false) shape:square]</url>
      <title>Chelation therapy</title>
      <link>/tags/chelation-therapy/</link>
    </image>
    
    <item>
      <title>From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents</title>
      <link>/publication/an-early-2017/</link>
      <pubDate>Sat, 01 Apr 2017 00:00:00 +0000</pubDate>
      <guid>/publication/an-early-2017/</guid>
      <description></description>
    </item>
    
    <item>
      <title>In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO)</title>
      <link>/publication/choi-vitro-2015/</link>
      <pubDate>Fri, 01 May 2015 00:00:00 +0000</pubDate>
      <guid>/publication/choi-vitro-2015/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
